Browsing by Author Kastelein, John J.P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2006Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) TrialsBarter, Philip; Cater, Nilo B; Demicco, David A; Gaffney, Michael; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, M; Central Clinical School: Heart Research InstituteAbstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials, Circulation (Baltimore), vol.114, N/A,pp II_713-II_714
2012ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE StudiesBarter, Philip; Ballantyne, C. M.; Borgman, Marilyn; Brewer, H Bryan; Gordon, Allan; Johannson, Jan; Kastelein, John J.P.; Nicholls, Stephen J; Nissen, Steven; Wong, Norman; Central Clinical School: Heart Research InstituteApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies, Cardiovascular Drugs and Therapy, vol.26, 2, 2012,pp 181-187
2006Effect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudyBarter, Philip; Kastelein, John J.P.; LaRosa, John C.; Shah, S.; Shepherd, James; Treating to New Targets, (TNT) Investigators; Waters, David D; Wenger, Nanette K.; Central Clinical School: Heart Research InstituteEffect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudy, European Heart Journal (English Edition), vol.27, Suppl 1,pp 943-N/A
2011Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) TrialBarter, Philip; Rye, Kerry-Anne; Boekholdt, S Matthijs; Breazna, Andrei; Kastelein, John J.P.; Tardif, Jean-Claude; Waters, David D; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research InstituteEffect of Torcetrapib on Glucose, Insulin, and Hemoglobin A1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial, Circulation (Baltimore), vol.124, 5, 2011,pp 555-562
2007Effects of Torcetrapib in Patients at High Risk for Coronary EventsBarter, Philip; Caulfield, Mark; Eriksson, Mats; et, al; Grundy, Scott M.; Kastelein, John J.P.; Komajda, Michel; Lopez-Sendon, Jose; Mosca, Lori; Tardif, Jean-Claude; Waters, David D; Central Clinical School: MedicineEffects of Torcetrapib in Patients at High Risk for Coronary Events, New England Journal of Medicine, vol.357,(21),2007,pp 2109-2122
2007HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular eventsBarter, Philip; Bittner, V; Fruchart, J; Gotto, A. M. G.; Grundy, Scott M; Kastelein, John J.P.; laRosa, John C; Maroni, J; Szarek, M; Central Clinical School: MedicineHDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, New England Journal of Medicine, vol.357,(13),2007,pp 1301-1310
2005Intensive lipid lowering with atorvastatin in patients with stable coronary disease.Barter, Philip; et al, various; Fruchart, Jean-Charles; Gotto, Antonio M.; Greten, Heiner; Grundy, Scott M.; Kastelein, John J.P.; LaRosa, John C.; Shear, Charles; Shepherd, James; Waters, David D; Wenger, Nanette K.; Central Clinical School: MedicineIntensive lipid lowering with atorvastatin in patients with stable coronary disease., New England Journal of Medicine, vol.352,(14),2005,pp 1425-35
2008Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin TreatmentBarter, Philip; Boekholdt, S Matthijs; Cater, Nilo B; Deedwania, Prakash; DeMicco, David A; Gaffney, Michael; Grundy, Scott M; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, Michael; van der Steeg, Wim A; Central Clinical School: Heart Research InstituteLipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment, Circulation, vol.117, 23, 2008,pp 3002-3009
2006On-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-C as Predictors of Cardiovascular Events in the Treating to New Targets (TNT) StudyBarter, Philip; Bittner, V; Fruchart, Jean-Charles; Gotto, Antonio M.; Grundy, Scott M.; Kastelein, John J.P.; LaRosa, John C.; Central Clinical School: Heart Research InstituteOn-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-C as Predictors of Cardiovascular Events in the Treating to New Targets (TNT) Study, Journal of the American College of Cardiology, vol.47, 4 Suppl A,pp 298A-N/A
2012Relationship between atorvastatin dose and the harm caused by torcetrapibRye, Kerry-Anne; Barter, Philip J.; Beltangady, Mohan S; Boekholdt, S Matthijs; DeMicco, David A; Duggan, William T.; Kastelein, John J.P.; Ports, William C; Shear, Charles; Central Clinical School: Heart Research InstituteRelationship between atorvastatin dose and the harm caused by torcetrapib, Journal of Lipid Research, vol.53, 11, 2012,pp 2436-2442
2006Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.Barter, Philip; Kastelein, John J.P.; Central Clinical School: MedicineTargeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease., Journal of the American College of Cardiology 2005, vol.47,(3),2006,pp 492-499
2006Translating today's science into clinical practiceBarter, Philip; Kastelein, John J.P.; Central Clinical School: Heart Research InstituteTranslating today's science into clinical practice, Atherosclerosis Supplements, vol.7,(1 Spec. Iss.),2006,pp 1-2